サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414298

色素沈着過剰障害治療の世界市場レポート 2024年

Hyperpigmentation Disorder Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
色素沈着過剰障害治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

色素沈着過剰障害治療市場規模は近年力強く成長しています。2023年の53億米ドルから2024年には56億9,000万米ドルへと、CAGR7.5％で拡大します。この期間に見られた拡大は、この分野における臨床試験や研究、ケミカルピーリング技術の進歩、スキンケアに対する文化的なシフト、非侵襲的な治療オプションの重視、天然製品に対する需要の増加などの要因によるものと考えられます。

色素沈着障害の有病率の増加が予想され、色素沈着障害治療市場の成長を促進すると予測されています。色素沈着障害は、皮膚、毛髪、眼虹彩の色調に影響を及ぼす様々な状態を包含し、典型的にはメラノサイトによって産生される色素であるメラニンの問題に起因します。色素沈着障害の治療法は、根本的な原因や重症度によって異なるが、軽症の場合は、アゼライン酸、システアミンクリーム、ビタミンC、ハイドロキノンなど、美白作用で知られる成分を含む市販の外用クリームで対処することが多いです。例えば、2023年3月の米国疾病管理センター（CDC）の報告では、米国におけるカンジダ・オーリスの症例数が2019年の476例から2021年には1,471例に増加することが強調されています。さらに、全米乾癬財団は2022年12月に、乾癬は全世界で1億2,500万人が罹患しており、これは全人口の2～3％に相当すると報告しています。色素沈着過剰障害の有病率の上昇は、色素沈着過剰障害治療市場の成長を促進すると予想されます。

北米は、2023年の色素沈着過剰障害治療市場において最大の地域でした。アジア太平洋は、予測期間中、世界の色素沈着過剰障害治療市場レポートにおいて最も急成長する地域となる見込みです。色素沈着過剰障害治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の色素沈着過剰障害治療市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の色素沈着過剰障害治療市場規模実績と成長、2018～2023年
  • 世界の色素沈着過剰障害治療市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の色素沈着過剰障害治療市場、治療タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 化粧品
  • レーザー治療
  • ケミカルピーリング
  • マイクロダーマブレーション
  • 光線療法
  • その他の治療法
  • 世界の色素沈着過剰障害治療市場、疾患適応別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 肝斑
  • 炎症後色素沈着過剰
  • 日光性黒子
  • その他の疾患の適応症
  • 世界の色素沈着過剰障害治療市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • エステティッククリニックと皮膚科センター
  • その他のエンドユーザー

第7章 地域と国の分析

  • 世界の色素沈着過剰障害治療市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の色素沈着過剰障害治療市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 色素沈着過剰障害治療市場の競合情勢
  • 色素沈着過剰障害治療市場の企業プロファイル
    • Vivier Pharma
    • Obagi Cosmeceuticals LLC
    • RXi Pharmaceuticals Corporation
    • EpiPharm AG
    • Laboratories Pierre Fabre

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

目次
Product Code: r11808

“Hyperpigmentation Disorder Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperpigmentation disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperpigmentation disorder treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hyperpigmentation disorder treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment Type: Cosmeceuticals; Laser Therapy; Chemical Peels; Microdermabrasion; Phototherapy; Other Treatments
  • 2) By Disease Indication: Melasma; Post-Inflammatory Hyperpigmentation; Solar Lentigines; Other Disease Indications
  • 3) By End-Users: Hospitals; Esthetic Clinics And Dermatology Centers; Other End-Users
  • Companies Mentioned: Vivier Pharma; Obagi Cosmeceuticals LLC; RXi Pharmaceuticals Corporation; EpiPharm AG; Laboratories Pierre Fabre
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hyperpigmentation disorder treatment involves various methods aimed at reducing the appearance of dark spots or patches on the skin caused by excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid are commonly used to lighten the skin.

Treatment types in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy, and other treatments. Cosmeceuticals are cosmetics with active ingredients that may have therapeutic effects on the skin. They are utilized to treat various conditions, including melasma, post-inflammatory hyperpigmentation, solar lentigines, and other indications. These treatments are administered by various end-users, including hospitals, esthetic clinics, dermatology centers, and other healthcare facilities.

The hyperpigmentation disorder treatment market research report is one of a series of new reports from The Business Research Company that provides hyperpigmentation disorder treatment optical components market statistics, including hyperpigmentation disorder treatment optical components industry global market size, regional shares, competitors with a hyperpigmentation disorder treatment optical components market share, detailed hyperpigmentation disorder treatment optical components market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment optical components industry. This hyperpigmentation disorder treatment optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.3 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The expansion observed during the historical period can be attributed to factors such as clinical trials and research in the field, advances in chemical peels technology, a cultural shift towards skincare, an emphasis on non-invasive treatment options, and an increasing demand for natural products in hyperpigmentation disorder treatment.

The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to a focus on non-invasive treatments, increased awareness of skincare, the adoption of telemedicine and virtual consultations, regulatory support and approvals for hyperpigmentation disorder treatments, and the availability of personalized treatment options. Major trends expected in the forecast period include the development of innovative topical formulations, advancements in laser technologies, a focus on combination therapies, personalized treatment approaches, and a rising demand for natural products in the hyperpigmentation disorder treatment market.

The expected increase in the prevalence of pigmentation disorders is anticipated to fuel the growth of the hyperpigmentation disorders treatment market. Pigmentation disorders encompass various conditions affecting the coloration of the skin, hair, and eye iris, typically resulting from issues with melanin, the pigment produced by melanocytes. Treatment options for hyperpigmentation disorders vary based on the underlying cause and severity, with mild cases often managed through over-the-counter topical creams containing ingredients such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone, known for their skin-lightening properties. For example, a report from the Centers for Disease Control (CDC) in March 2023 highlighted an increase in Candida auris cases in the US from 476 in 2019 to 1,471 in 2021. Additionally, the National Psoriasis Foundation reported in December 2022 that psoriasis affects 125 million people globally, representing 2 to 3 percent of the overall population. The rise in pigmentation disorders' prevalence is expected to drive the growth of the hyperpigmentation disorders treatment market.

The growth of the hyperpigmentation disorder treatment market is further propelled by increasing cosmetic concerns. Cosmetic concerns refer to worries or considerations related to one's physical appearance, beauty, or aesthetics. The rising focus on cosmetic concerns encourages individuals to seek hyperpigmentation disorder treatments, fostering innovation in the cosmetic and dermatological industries and enhancing the overall patient experience. Reports from the International Society of Aesthetic Plastic Surgery (ISAPS) in September 2023 revealed that plastic surgeons are expected to perform over 14.9 million surgical and 18.8 million non-surgical operations in 2022, reflecting an overall increase of 11.2%. The heightened emphasis on cosmetic concerns is a significant driver behind the growth of the hyperpigmentation disorder treatment market.

A prominent trend in the hyperpigmentation disorders treatment market is the focus on product innovation by major companies striving to bolster their positions and gain a competitive advantage. An illustration of this trend is evident in the actions of Uniza Healthcare, an India-based pharmaceutical company, which, in October 2021, introduced a groundbreaking treatment product named Vitellus. This lotion, comprising a distinctive blend of EUK-134, Greyverse, and Melitane GL 200, not only stimulates melanin growth but also addresses skin pigmentation, hair follicle pigmentation, and acts as a potent antioxidant.

Major players in the hyperpigmentation disorder treatment market are strategically launching innovative products to meet the growing demand for effective and safe hyperpigmentation treatment. A noteworthy example is the Cyspera Intensive System, unveiled by Cyspera (Scientis SA), a Switzerland-based dermatology company, in June 2021. This revolutionary three-step hyperpigmentation treatment is meticulously designed to target persistent brown patches and dark spots. The system features a proprietary Cysteamine Isobionic-Amide Complex, a patented melanosomal transfer inhibitor within the vitamin B3 family. This complex collaborates synergistically with cysteamine to deliver three powerful effects. In essence, the Cyspera Intensive System emerges as a promising new option for hyperpigmentation treatment, ensuring safety and efficacy for all skin types without harsh chemicals.

In December 2021, DermBiont, Inc., a US-based biotechnology company, executed the acquisition of Chroma Dermatology. The undisclosed amount spent on this acquisition enabled DermBiont to diversify its drug pipeline, incorporating expertise in managing various skin hyperpigmentation conditions such as melasma and solar lentigos. This expansion complements DermBiont's existing focus on conditions such as seborrheic keratosis, atopic dermatitis, seborrheic dermatitis, and acne. Chroma Dermatology, as a US-based clinical-stage biotechnology company, became an integral part of DermBiont's comprehensive approach to dermatological solutions.

Major companies operating in the hyperpigmentation disorder treatment market report are Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L'Oreal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estee Lauder Companies Inc.

North America was the largest region in the hyperpigmentation disorders treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hyperpigmentation Disorder Treatment Market Characteristics

3. Hyperpigmentation Disorder Treatment Market Trends And Strategies

4. Hyperpigmentation Disorder Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Hyperpigmentation Disorder Treatment Market Size and Growth

  • 5.1. Global Hyperpigmentation Disorder Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hyperpigmentation Disorder Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hyperpigmentation Disorder Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hyperpigmentation Disorder Treatment Market Segmentation

  • 6.1. Global Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cosmeceuticals
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
  • Other Treatments
  • 6.2. Global Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Melasma
  • Post-Inflammatory Hyperpigmentation
  • Solar Lentigines
  • Other Disease Indications
  • 6.3. Global Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Esthetic Clinics And Dermatology Centers
  • Other End-Users

7. Hyperpigmentation Disorder Treatment Market Regional And Country Analysis

  • 7.1. Global Hyperpigmentation Disorder Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hyperpigmentation Disorder Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hyperpigmentation Disorder Treatment Market

  • 8.1. Asia-Pacific Hyperpigmentation Disorder Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hyperpigmentation Disorder Treatment Market

  • 9.1. China Hyperpigmentation Disorder Treatment Market Overview
  • 9.2. China Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hyperpigmentation Disorder Treatment Market

  • 10.1. India Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hyperpigmentation Disorder Treatment Market

  • 11.1. Japan Hyperpigmentation Disorder Treatment Market Overview
  • 11.2. Japan Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hyperpigmentation Disorder Treatment Market

  • 12.1. Australia Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hyperpigmentation Disorder Treatment Market

  • 13.1. Indonesia Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hyperpigmentation Disorder Treatment Market

  • 14.1. South Korea Hyperpigmentation Disorder Treatment Market Overview
  • 14.2. South Korea Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hyperpigmentation Disorder Treatment Market

  • 15.1. Western Europe Hyperpigmentation Disorder Treatment Market Overview
  • 15.2. Western Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hyperpigmentation Disorder Treatment Market

  • 16.1. UK Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hyperpigmentation Disorder Treatment Market

  • 17.1. Germany Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hyperpigmentation Disorder Treatment Market

  • 18.1. France Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hyperpigmentation Disorder Treatment Market

  • 19.1. Italy Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hyperpigmentation Disorder Treatment Market

  • 20.1. Spain Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hyperpigmentation Disorder Treatment Market

  • 21.1. Eastern Europe Hyperpigmentation Disorder Treatment Market Overview
  • 21.2. Eastern Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hyperpigmentation Disorder Treatment Market

  • 22.1. Russia Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hyperpigmentation Disorder Treatment Market

  • 23.1. North America Hyperpigmentation Disorder Treatment Market Overview
  • 23.2. North America Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hyperpigmentation Disorder Treatment Market

  • 24.1. USA Hyperpigmentation Disorder Treatment Market Overview
  • 24.2. USA Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hyperpigmentation Disorder Treatment Market

  • 25.1. Canada Hyperpigmentation Disorder Treatment Market Overview
  • 25.2. Canada Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hyperpigmentation Disorder Treatment Market

  • 26.1. South America Hyperpigmentation Disorder Treatment Market Overview
  • 26.2. South America Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hyperpigmentation Disorder Treatment Market

  • 27.1. Brazil Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hyperpigmentation Disorder Treatment Market

  • 28.1. Middle East Hyperpigmentation Disorder Treatment Market Overview
  • 28.2. Middle East Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hyperpigmentation Disorder Treatment Market

  • 29.1. Africa Hyperpigmentation Disorder Treatment Market Overview
  • 29.2. Africa Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hyperpigmentation Disorder Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Hyperpigmentation Disorder Treatment Market Competitive Landscape
  • 30.2. Hyperpigmentation Disorder Treatment Market Company Profiles
    • 30.2.1. Vivier Pharma
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Obagi Cosmeceuticals LLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. RXi Pharmaceuticals Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. EpiPharm AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratories Pierre Fabre
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Hyperpigmentation Disorder Treatment Market Competitive Benchmarking

32. Global Hyperpigmentation Disorder Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hyperpigmentation Disorder Treatment Market

34. Hyperpigmentation Disorder Treatment Market Future Outlook and Potential Analysis

  • 34.1 Hyperpigmentation Disorder Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Hyperpigmentation Disorder Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Hyperpigmentation Disorder Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer